Identification of the novel splicing variants for the hPXR in human livers

Biochemical and Biophysical Research Communications

Volumn 298, Issue 3, 2002, Pages 433-438

  Fukuen, Shuichi ^a   Fukuda, Tsuyoshi ^a   Matsuda, Hideyasu ^a   Sumida, Akihiko ^a   Yamamoto, Isamu ^a   Inaba, Tadanobu ^b   Azuma, Junichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alternative splicing; CYP3A4; Drug metabolism; HPXR; Human liver; P Glycoprotein; RT PCR; Splicing variant

Indexed keywords

CYTOCHROME P450 3A4; GLYCOPROTEIN P; PREGNANE X RECEPTOR;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LIVER; MDR1 GENE; PRIORITY JOURNAL; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 0036431890     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02469-5     Document Type: Article

References (23)

1. J.M. Lehmann, D.D. McKee, M.A. Watson, T.M. Willson, J.T. Moore, S.A. Kliewer, The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions, J. Clin. Invest. 102 (1998) 1016-1023.
2. B. Blumberg, W.J. Sabbagh, H. Juguilon, J.J. Bolado, C.M. van Meter, E.S. Ong, R.M. Evans, SXR, a novel steroid and xenobiotic-sensing nuclear receptor, Genes Dev. 12 (1998) 3195-3205.
3. G. Bertilsson, J. Heidrich, K. Svensson, M. Asman, L. Jendeberg, B.M. Sydow, R. Ohlsson, H. Postlind, P. Blomquist, A. Berken-stam, Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction, Proc. Natl. Acad. Sci. USA 95 (1998) 12208-12213.
4. T.W. Synold, I. Dussault, B.M. Forman, The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux, Nat. Med. 7 (2001) 584-590.
5. E. Schuetz, S. Strom, Promiscuous regulator of xenobiotic removal, Nat. Med. 7 (2001) 536-537.
6. S.A. Jones, L.B. Moore, J.L. Shenk, G.B. Wisely, G.A. Hamilton, D.D. McKee, N.C. Tomkinson, E.L. LeCluyse, M.H. Lambert, T.M. Willson, S.A. Kliewer, J.T. Moore, The pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution, Mol. Endocrinol. 14 (2000) 27-39.
7. L.B. Moore, B. Goodwin, S.A. Jones, G.B. Wisely, S.C. Serabjit, T.M. Willson, J.L. Collins, S.A. Kliewer, St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor, Proc. Natl. Acad. Sci. USA 97 (2000) 7500-7502.
8. W. Xie, J.L. Barwick, M. Downes, B. Blumberg, C.M. Simon, M.C. Nelson, T.B. Neuschwander, E.M. Brunt, P.S. Guzelian, R.M. Evans, Humanized xenobiotic response in mice expressing nuclear receptor SXR, Nature 406 (2000) 435-439.
9. S.M. Borcherding, A.M. Baciewicz, T.H. Self, Update on rifampin drug interactions II, Arch. Intern. Med. 152 (1992) 711-716.
10. W. Perry, M.V. Jenkins, Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians, Int. J. Clin. Pharmacol. Ther. Toxicol. 24 (1986) 344-348.
11. P.B. Watkins, S.A. Murray, L.G. Winkelman, D.M. Heuman, S.A. Wrighton, P.S. Guzelian, Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients, J. Clin. Invest. 83 (1989) 688-697.
12. J.C. Kolars, R.P. Schmiedlin, J.D. Schuetz, C. Fang, P.B. Watkins, Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes, J. Clin. Invest. 90 (1992) 1871-1878.
13. B. Greiner, M. Eichelbaum, P. Fritz, H.P. Kreichgauer, O. von Richter, J. Zundler, H.K. Kroemer, The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin, J. Clin. Invest. 104 (1999) 147-153.
14. H. Dotzlaw, E. Leygue, P. Watson, L.C. Murphy, The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue, Clin. Cancer Res. 5 (1999) 2103-2107.
15. E. Hustert, A. Zibat, S.E. Presecan, R. Eiselt, R. Mueller, C. Fuss, I. Brehm, U. Brinkmann, M. Eichelbaum, L. Wojnowski, O. Burk, Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4, Drug Metab. Dispos. 29 (2001) 1454-1459.
16. A. Sumida, K. Kinoshita, T. Fukuda, H. Matsuda, I. Yamamoto, T. Inaba, J. Azuma, Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver, Biochem. Biophys. Res. Commun. 262 (1999) 499-503.
17. International Human Genome Sequencing Consortium, Initial sequencing and analysis of the human genome, Nature 409 (2001) 860-921.
18. Z. Kan, E.C. Rouchka, W.R. Gish, D.J. States, Gene structure prediction and alternative splicing analysis using genomically aligned ESTs, Genome Res. 11 (2001) 889-900.
19. B. Modrek, A. Resch, C. Grasso, C. Lee, Genome-wide detection of alternative splicing in expressed sequences of human genes, Nucleic Acids Res. 29 (2001) 2850-2859.
20. C.W. Smith, J.G. Patton, G.B. Nadal, Alternative splicing in the control of gene expression, Annu. Rev. Genet. 23 (1989) 527-577.
21. M.C. Keightley, Steroid receptor isoforms: Exception or rule? Mol. Cell. Endocrinol. 137 (1998) 1-5.
22. P. Kuehl, J. Zhang, Y. Lin, J. Lamba, M. Assem, J. Schuetz, P.B. Watkins, A. Daly, S.A. Wrighton, S.D. Hall, P. Maurel, M. Relling, C. Brimer, K. Yasuda, R. Venkataramanan, S. Strom, K. Thummel, M.S. Boguski, E. Schuetz, Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression, Nat. Genet. 27 (2001) 383-391.
23. J. Zhang, P. Kuehl, E.D. Green, J.W. Touchman, P.B. Watkins, A. Daly, S.D. Hall, P. Maurel, M. Relling, C. Brimer, K. Yasuda, S.A. Wrighton, M. Hancock, R.B. Kim, S. Strom, K. Thummel, C.G. Russell, J.J. Hudson, E.G. Schuetz, M.S. Boguski, The human pregnane X receptor: Genomic structure and identification and functional characterization of natural allelic variants, Pharmacogenetics 11 (2001) 555-572.